Basel Medical Group Ltd
BMGL
$4.41
$0.102.32%
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 275.70K | 278.40K | 491.60K | 491.60K | 440.40K |
| Total Depreciation and Amortization | 97.40K | 98.30K | 98.30K | 98.30K | 88.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -94.20K | -95.10K | 62.10K | 62.10K | 77.70K |
| Change in Net Operating Assets | 595.00K | 600.80K | -598.70K | -598.70K | -34.90K |
| Cash from Operations | 873.80K | 882.40K | 53.30K | 53.30K | 571.30K |
| Capital Expenditure | 0.00 | 0.00 | -2.90K | -2.90K | -600.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 0.00 | -2.90K | -2.90K | -600.00 |
| Total Debt Issued | 136.80K | 136.80K | 574.60K | 574.60K | -4.65M |
| Total Debt Repaid | -682.00K | -682.00K | -779.50K | -779.50K | 3.78M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -133.80K | -133.80K | -- | -- | 200.00 |
| Cash from Financing | -501.70K | -506.60K | -151.90K | -151.90K | -646.90K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 372.20K | 375.80K | -101.50K | -101.50K | -76.20K |